Lymphoma

In patients with diffuse large B-cell lymphoma, low muscle mass (LMM) and low muscle density (LMD) could play a role when deciding what kind of treatment option to pursue, and could also impact a patient’s odds of survival, according to a recent study.

“Unlike other CAR T-cell therapies, clinical success was not associated with significant complications from therapy,” said Dr. Jonathan Serody. “This means this treatment should be available to patients in a clinic setting and would not require patients to be hospitalized, which is critical in our current environment.”

After a cancer diagnosis, Maryland Governor Larry Hogan had to lean on family from both his personal and professional life to helping take on treatment and beat cancer twice.

In this week’s episode of the CURE Talks Cancer podcast, Maryland Governor Larry Hogan opens up about what it was like to go through cancer not once but twice, and why he considers every day a gift.

Here, a survivor lists some alternative ways that patients with cancer or survivors in need of flexible employment can earn extra money.

Ethan Zohn, "Survivor: Africa" winner, discusses how his winner’s mentality helped him through treatment and how leaning on others has been key in survivorship.

From a new trial in Canada looking at therapeutics to help prevent severe symptoms of COVID-19 in patients with cancer to updated guidelines from the American Cancer Society on taking the HPV vaccine to prevent certain cancers, here’s what’s making the headlines in the cancer space this week.

“Let's try to make something good out of something really bad,” says “Survivor: Africa” winner, and lymphoma survivor, Ethan Zohn.

The Food and Drug Administration has had a busy couple of weeks, approving new agents to treat a variety of cancers. Here are five recent approvals that patients with cancer may have missed.

The Food and Drug Administration granted accelerated approval to Xpovio for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma who have undergone two prior therapies.

Dr. Caron A. Jacobson discusses the potential long-term impact of Yescarta for patients with relapsed or refractory indolent non-Hodgkin lymphoma and how it could turn an incurable disease into something curable.

“Survivor: Africa” winner Ethan Zohn details his journey with cancer and discovering that it isn’t a sprint, but a marathon.

Data presented at the ASCO 2020 Virtual Scientific Program demonstrated that Keytruda was an effective treatment for patients with Hodgkin Lymphoma and side effects were tolerable.

Being a young adult with cancer can feel like an isolating journey, but "Survivor: Africa" winner Ethan Zohn details how a community can form even in the unlikeliest of places.

In an interview with CURE, “Survivor: Africa” winner Ethan Zohn talks about how his cancer journey changed his perspective on life and helps him to navigate the COVID-19 pandemic.

On this week’s episode of the “CURE Talks Cancer” podcast, we spoke with “Survivor: Africa” winner Ethan Zohn on his journey with cancer and advocating for lymphoma awareness.

The allogeneic “off-the-shelf” CAR-T cell therapy ALLO-501, paired with the monoclonal antibody ALLO-647, demonstrated clinical responses and a manageable safety profile in patients with pretreated large B-cell and follicular lymphomas.

Former Survivor competitor, and winner, Ethan Zohn talks with CURE about his journey with cancer and raising awareness for patients with leukemia and lymphoma.

A diffuse large B-cell lymphoma survivor shares her frank and funny view of coping with cancer.

One survivor has advice for others affected by both cancer and the COVID-19 pandemic: Accept your limitations.

Dealing with the challenges of health and wellness after cancer treatment is tricky enough, but managing it in the midst of the COVID-19 pandemic is an even bigger obstacle. One survivor details how she tries to take it one wellness win at a time.

One survivor describes her journey with breast implant associated anaplastic large cell lymphoma, and how she advocates for more awareness to protect future patients.

Dr. Wendy S. Harpham’s e-book “Finding Hope That Heals” looks to help patients with cancer craft, and achieve, attainable goals on their cancer journey.

From a 105-year-old cancer survivor recovering from COVID-19 to a 7-year-old finishing his last chemotherapy treatment for lymphoma and also beating COVID-19, here’s what’s making the headlines in the cancer landscape this week.